Seth Rudnick, Director at G1 Therapeutics, Inc. (GTHX), sold 10,000 shares at $50.69 ($507K) on 2018-08-06, disclosed to the SEC on 2018-08-06.
Open-market sale of $507k GTHX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| GTHX | SELL | 2020-12-23 | $1.3M | — | Filing → |
| GTHX | SELL | 2020-12-10 | $777K | — | Filing → |
| GTHX | SELL | 2020-12-03 | $10K | — | Filing → |